{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T22:07:58Z","timestamp":1788214078073,"version":"build-2803163510"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100021772","name":"Deanship of Scientific Research, University of Jordan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021772","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Deliv. and Transl. Res."],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s13346-024-01706-7","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T17:02:04Z","timestamp":1727110924000},"page":"1707-1718","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["In vitro and in vivo evaluation of in situ forming polyester implants for the extended release of carvedilol"],"prefix":"10.1007","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7980-7429","authenticated-orcid":false,"given":"Samer R.","family":"Abulateefeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghad M.","family":"Abuhamdan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Husam","family":"Saed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alsalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaldoun","family":"Shnewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,23]]},"reference":[{"key":"1706_CR1","doi-asserted-by":"publisher","unstructured":"Bennett JE, Stevens GA, Mathers CD, et al. NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4. The Lancet. 2018;392(10152):1072\u20131088. https:\/\/doi.org\/10.1016\/S0140-6736(18)31992-5","DOI":"10.1016\/S0140-6736(18)31992-5"},{"key":"1706_CR2","doi-asserted-by":"publisher","first-page":"101860","DOI":"10.1016\/j.eclinm.2023.101860","volume":"57","author":"SR Chowdhury","year":"2023","unstructured":"Chowdhury SR, Chandra Das D, Sunna TC, Beyene J, Hossain A. Global and regional prevalence of multimorbidity in the adult population in community settings: a systematic review and meta-analysis. EClinicalMedicine. 2023;57:101860. https:\/\/doi.org\/10.1016\/j.eclinm.2023.101860.","journal-title":"EClinicalMedicine"},{"issue":"3","key":"1706_CR3","doi-asserted-by":"publisher","first-page":"e003377","DOI":"10.1136\/bmjdrc-2023-003377","volume":"11","author":"A Alkandari","year":"2023","unstructured":"Alkandari A, Vaucher J, Marques-Vidal P. Trends in glycemic, blood pressure, and lipid control in adults with diabetes in Switzerland: the CoLaus|PsyCoLaus Study. BMJ Open Diabetes Res Care. 2023;11(3):e003377. https:\/\/doi.org\/10.1136\/bmjdrc-2023-003377.","journal-title":"BMJ Open Diabetes Res Care"},{"key":"1706_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejim.2023.07.008","volume":"119","author":"M Burnier","year":"2024","unstructured":"Burnier M. The role of adherence in patients with chronic diseases. Eur J Intern Med. 2024;119:1\u20135. https:\/\/doi.org\/10.1016\/j.ejim.2023.07.008.","journal-title":"Eur J Intern Med"},{"key":"1706_CR5","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.ijpharm.2019.01.006","volume":"558","author":"SR Abulateefeh","year":"2019","unstructured":"Abulateefeh SR, Alkawareek MY, Alkilany AM. Tunable sustained release drug delivery system based on mononuclear aqueous core-polymer shell microcapsules. Int J Pharm. 2019;558:291\u20138. https:\/\/doi.org\/10.1016\/j.ijpharm.2019.01.006.","journal-title":"Int J Pharm"},{"key":"1706_CR6","doi-asserted-by":"publisher","unstructured":"Abuhamdan RM, Al-Anati BH, Al Thaher Y, Shraideh ZA, Alkawareek MY, Abulateefeh SR. Aqueous core microcapsules as potential long-acting release systems for hydrophilic drugs. Int J Pharm. 2021;606. https:\/\/doi.org\/10.1016\/j.ijpharm.2021.120926","DOI":"10.1016\/j.ijpharm.2021.120926"},{"key":"1706_CR7","doi-asserted-by":"publisher","unstructured":"Alhawari HH, Abuhamdan RM, Alrashdan M, Al Thaher Y, Shraideh ZA, Abulateefeh SR. Development and In Vivo Evaluation of Sustained Release Microparticles Loaded with Levothyroxine for Hypothyroidism Treatment. J Pharm Sci. Published online January 2024. https:\/\/doi.org\/10.1016\/j.xphs.2024.01.004","DOI":"10.1016\/j.xphs.2024.01.004"},{"key":"1706_CR8","doi-asserted-by":"publisher","first-page":"113957","DOI":"10.1016\/j.addr.2021.113957","volume":"177","author":"H Abdelkader","year":"2021","unstructured":"Abdelkader H, Fathalla Z, Seyfoddin A, et al. Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: Inserts, patches, wafers, and implants. Adv Drug Deliv Rev. 2021;177:113957. https:\/\/doi.org\/10.1016\/j.addr.2021.113957.","journal-title":"Adv Drug Deliv Rev"},{"issue":"6","key":"1706_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1023\/A:1015818504906","volume":"08","author":"H Okada","year":"1991","unstructured":"Okada H, Inoue Y, Heya T, Ueno H, Ogawa Y, Toguchi H. Pharmacokinetics of once-a-month injectable microspheres of leuprolide acetate. Pharm Res. 1991;08(6):787\u201391. https:\/\/doi.org\/10.1023\/A:1015818504906.","journal-title":"Pharm Res"},{"key":"1706_CR10","doi-asserted-by":"publisher","unstructured":"Lee WY, Asadujjaman Md, Jee JP. Long acting injectable formulations: the state of the arts and challenges of poly(lactic-co-glycolic acid) microsphere, hydrogel, organogel and liquid crystal. J Pharm Investig. 2019;49(4):459\u2013476. https:\/\/doi.org\/10.1007\/s40005-019-00449-9","DOI":"10.1007\/s40005-019-00449-9"},{"issue":"2","key":"1706_CR11","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ejpb.2004.03.003","volume":"58","author":"CB Packhaeuser","year":"2004","unstructured":"Packhaeuser CB, Schnieders J, Oster CG, Kissel T. In situ forming parenteral drug delivery systems: an overview. Eur J Pharm Biopharm. 2004;58(2):445\u201355. https:\/\/doi.org\/10.1016\/j.ejpb.2004.03.003.","journal-title":"Eur J Pharm Biopharm"},{"key":"1706_CR12","unstructured":"Richard L. Dunn, James P. English, Donald R. Cowsar, David P. Vanderbilt. Biodegradable in-situ forming implants and methods of producing the same. Published online July 3, 1990."},{"key":"1706_CR13","doi-asserted-by":"publisher","first-page":"113912","DOI":"10.1016\/j.addr.2021.113912","volume":"178","author":"X Wang","year":"2021","unstructured":"Wang X, Burgess DJ. Drug release from in situ forming implants and advances in release testing. Adv Drug Deliv Rev. 2021;178:113912. https:\/\/doi.org\/10.1016\/j.addr.2021.113912.","journal-title":"Adv Drug Deliv Rev"},{"issue":"5","key":"1706_CR14","doi-asserted-by":"publisher","first-page":"2763","DOI":"10.1007\/s00289-020-03347-5","volume":"79","author":"MS Amini-Fazl","year":"2022","unstructured":"Amini-Fazl MS. Biodegradation study of PLGA as an injectable in situ depot-forming implant for controlled release of paclitaxel. Polym Bull. 2022;79(5):2763\u201376. https:\/\/doi.org\/10.1007\/s00289-020-03347-5.","journal-title":"Polym Bull"},{"issue":"1","key":"1706_CR15","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1038\/s41467-019-12141-5","volume":"10","author":"SR Benhabbour","year":"2019","unstructured":"Benhabbour SR, Kovarova M, Jones C, et al. Ultra-long-acting tunable biodegradable and removable controlled release implants for drug delivery. Nat Commun. 2019;10(1):4324. https:\/\/doi.org\/10.1038\/s41467-019-12141-5.","journal-title":"Nat Commun"},{"issue":"9","key":"1706_CR16","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1039\/C6RA27676H","volume":"7","author":"L Wang","year":"2017","unstructured":"Wang L, Lin X, Hong Y, Shen L, Feng Y. Hydrophobic mixed solvent induced PLGA-based in situ forming systems for smooth long-lasting delivery of Radix Ophiopogonis polysaccharide in rats. RSC Adv. 2017;7(9):5349\u201361. https:\/\/doi.org\/10.1039\/C6RA27676H.","journal-title":"RSC Adv"},{"key":"1706_CR17","doi-asserted-by":"publisher","first-page":"106607","DOI":"10.1016\/j.ejps.2023.106607","volume":"191","author":"R Ashfaq","year":"2023","unstructured":"Ashfaq R, Sisa B, Kov\u00e1cs A, et al. Factorial design of in situ gelling two-compartment systems containing chlorhexidine for the treatment of periodontitis. Eur J Pharm Sci. 2023;191:106607. https:\/\/doi.org\/10.1016\/j.ejps.2023.106607.","journal-title":"Eur J Pharm Sci"},{"issue":"9","key":"1706_CR18","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1080\/10837450.2023.2267673","volume":"28","author":"M Alrashdan","year":"2023","unstructured":"Alrashdan M, Shraideh ZA, Abulateefeh SR. Optimizing formulation parameters for the development of carvedilol injectable in situ forming depots. Pharm Dev Technol. 2023;28(9):865\u201376. https:\/\/doi.org\/10.1080\/10837450.2023.2267673.","journal-title":"Pharm Dev Technol"},{"issue":"3","key":"1706_CR19","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0168-3659(99)00159-5","volume":"62","author":"KJ Brodbeck","year":"1999","unstructured":"Brodbeck KJ, DesNoyer JR, McHugh AJ. Phase inversion dynamics of PLGA solutions related to drug delivery. J Control Release. 1999;62(3):333\u201344. https:\/\/doi.org\/10.1016\/S0168-3659(99)00159-5.","journal-title":"J Control Release"},{"issue":"1\u20133","key":"1706_CR20","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.jconrel.2005.09.038","volume":"109","author":"AJ McHugh","year":"2005","unstructured":"McHugh AJ. The role of polymer membrane formation in sustained release drug delivery systems. J Control Release. 2005;109(1\u20133):211\u201321. https:\/\/doi.org\/10.1016\/j.jconrel.2005.09.038.","journal-title":"J Control Release"},{"key":"1706_CR21","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jconrel.2023.08.029","volume":"361","author":"X Wang","year":"2023","unstructured":"Wang X, Bao Q, Wang R, et al. In situ forming risperidone implants: Effect of PLGA attributes on product performance. J Control Release. 2023;361:777\u201391. https:\/\/doi.org\/10.1016\/j.jconrel.2023.08.029.","journal-title":"J Control Release"},{"issue":"2","key":"1706_CR22","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1007\/s13346-022-01228-0","volume":"13","author":"SR Abulateefeh","year":"2023","unstructured":"Abulateefeh SR. Long-acting injectable PLGA\/PLA depots for leuprolide acetate: successful translation from bench to clinic. Drug Deliv Transl Res. 2023;13(2):520\u201330. https:\/\/doi.org\/10.1007\/s13346-022-01228-0.","journal-title":"Drug Deliv Transl Res"},{"key":"1706_CR23","doi-asserted-by":"publisher","first-page":"119339","DOI":"10.1016\/j.ijpharm.2020.119339","volume":"582","author":"M Kohno","year":"2020","unstructured":"Kohno M, Andhariya JV, Wan B, et al. The effect of PLGA molecular weight differences on risperidone release from microspheres. Int J Pharm. 2020;582:119339. https:\/\/doi.org\/10.1016\/j.ijpharm.2020.119339.","journal-title":"Int J Pharm"},{"issue":"4","key":"1706_CR24","doi-asserted-by":"publisher","first-page":"2602","DOI":"10.1021\/acs.chemrev.5b00346","volume":"116","author":"N Kamaly","year":"2016","unstructured":"Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release. Chem Rev. 2016;116(4):2602\u201363. https:\/\/doi.org\/10.1021\/acs.chemrev.5b00346.","journal-title":"Chem Rev"},{"key":"1706_CR25","doi-asserted-by":"publisher","unstructured":"S P, R R, R K. Blood sample collection in small laboratory animals. J Pharmacol Pharmacother. 2010;1(2):87\u201393. https:\/\/doi.org\/10.4103\/0976-500X.72350","DOI":"10.4103\/0976-500X.72350"},{"key":"1706_CR26","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jconrel.2013.12.020","volume":"176","author":"RRS Thakur","year":"2014","unstructured":"Thakur RRS, McMillan HL, Jones DS. Solvent induced phase inversion-based in situ forming controlled release drug delivery implants. J Control Release. 2014;176:8\u201323. https:\/\/doi.org\/10.1016\/j.jconrel.2013.12.020.","journal-title":"J Control Release"},{"issue":"3","key":"1706_CR27","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/0011-9164(95)00076-3","volume":"103","author":"TH Young","year":"1995","unstructured":"Young TH, Chen LW. Pore formation mechanism of membranes from phase inversion process. Desalination. 1995;103(3):233\u201347. https:\/\/doi.org\/10.1016\/0011-9164(95)00076-3.","journal-title":"Desalination"},{"issue":"7","key":"1706_CR28","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s11095-022-03391-y","volume":"40","author":"A Bauer","year":"2023","unstructured":"Bauer A, Berben P, Chakravarthi SS, et al. Current State and Opportunities with Long-acting Injectables: Industry Perspectives from the Innovation and Quality Consortium \u201cLong-Acting Injectables\u201d Working Group. Pharm Res. 2023;40(7):1601\u201331. https:\/\/doi.org\/10.1007\/s11095-022-03391-y.","journal-title":"Pharm Res"},{"issue":"9","key":"1706_CR29","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1038\/nrd4363","volume":"13","author":"S Mitragotri","year":"2014","unstructured":"Mitragotri S, Burke PA, Langer R. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies. Nat Rev Drug Discov. 2014;13(9):655\u201372. https:\/\/doi.org\/10.1038\/nrd4363.","journal-title":"Nat Rev Drug Discov"},{"key":"1706_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.preteyeres.2014.04.002","volume":"42","author":"R Herrero-Vanrell","year":"2014","unstructured":"Herrero-Vanrell R, Bravo-Osuna I, Andr\u00e9s-Guerrero V, Vicario-de-la-Torre M, Molina-Mart\u00ednez IT. The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies. Prog Retin Eye Res. 2014;42:27\u201343. https:\/\/doi.org\/10.1016\/j.preteyeres.2014.04.002.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"1706_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1089\/jop.2010.0082","volume":"27","author":"EB Rodrigues","year":"2011","unstructured":"Rodrigues EB, Grumann A, Penha FM, et al. Effect of Needle Type and Injection Technique on Pain Level and Vitreal Reflux in Intravitreal Injection. J Ocul Pharmacol Ther. 2011;27(2):197\u2013203. https:\/\/doi.org\/10.1089\/jop.2010.0082.","journal-title":"J Ocul Pharmacol Ther"},{"issue":"1\u20132","key":"1706_CR32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.ijpharm.2007.04.034","volume":"342","author":"S Chhabra","year":"2007","unstructured":"Chhabra S, Sachdeva V, Singh S. Influence of end groups on in vitro release and biological activity of lysozyme from a phase-sensitive smart polymer-based in situ gel forming controlled release drug delivery system. Int J Pharm. 2007;342(1\u20132):72\u20137. https:\/\/doi.org\/10.1016\/j.ijpharm.2007.04.034.","journal-title":"Int J Pharm"},{"issue":"3","key":"1706_CR33","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1208\/s12249-008-9126-9","volume":"9","author":"HA Gad","year":"2008","unstructured":"Gad HA, El-Nabarawi MA, Abd El-Hady SS. Formulation and Evaluation of PLA and PLGA In Situ Implants Containing Secnidazole and\/or Doxycycline for Treatment of Periodontitis. AAPS PharmSciTech. 2008;9(3):878. https:\/\/doi.org\/10.1208\/s12249-008-9126-9.","journal-title":"AAPS PharmSciTech"},{"issue":"1","key":"1706_CR34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jconrel.2013.08.024","volume":"172","author":"M Parent","year":"2013","unstructured":"Parent M, Nouvel C, Koerber M, Sapin A, Maincent P, Boudier A. PLGA in situ implants formed by phase inversion: Critical physicochemical parameters to modulate drug release. J Control Release. 2013;172(1):292\u2013304. https:\/\/doi.org\/10.1016\/j.jconrel.2013.08.024.","journal-title":"J Control Release"},{"issue":"1","key":"1706_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/2193-8865-3-26","volume":"3","author":"MH Sadr","year":"2013","unstructured":"Sadr MH, Nabipour H. Synthesis and identification of carvedilol nanoparticles by ultrasound method. J Nanostructure Chem. 2013;3(1):26. https:\/\/doi.org\/10.1186\/2193-8865-3-26.","journal-title":"J Nanostructure Chem"},{"issue":"2","key":"1706_CR36","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s13346-018-0491-y","volume":"9","author":"R Sheshala","year":"2019","unstructured":"Sheshala R, Hong GC, Yee WP, Meka VS, Thakur RRS. In situ forming phase-inversion implants for sustained ocular delivery of triamcinolone acetonide. Drug Deliv Transl Res. 2019;9(2):534\u201342. https:\/\/doi.org\/10.1007\/s13346-018-0491-y.","journal-title":"Drug Deliv Transl Res"},{"issue":"7","key":"1706_CR37","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1002\/pat.3991","volume":"28","author":"M Enayati","year":"2017","unstructured":"Enayati M, Mobedi H, Hojjati-Emami S, Mirzadeh H, Jafari-Nodoushan M. In situ forming PLGA implant for 90 days controlled release of leuprolide acetate for treatment of prostate cancer. Polym Adv Technol. 2017;28(7):867\u201375. https:\/\/doi.org\/10.1002\/pat.3991.","journal-title":"Polym Adv Technol"},{"issue":"1\u20134","key":"1706_CR38","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1163\/092050610X549171","volume":"23","author":"H Liu","year":"2012","unstructured":"Liu H, Venkatraman SS. Effect of Polymer Type on the Dynamics of Phase Inversion and Drug Release in Injectable In Situ Gelling Systems. J Biomater Sci Polym Ed. 2012;23(1\u20134):251\u201366. https:\/\/doi.org\/10.1163\/092050610X549171.","journal-title":"J Biomater Sci Polym Ed"},{"key":"1706_CR39","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.jconrel.2019.07.019","volume":"309","author":"KA Hopkins","year":"2019","unstructured":"Hopkins KA, Vike N, Li X, et al. Noninvasive characterization of in situ forming implant diffusivity using diffusion-weighted MRI. J Control Release. 2019;309:289\u2013301. https:\/\/doi.org\/10.1016\/j.jconrel.2019.07.019.","journal-title":"J Control Release"},{"issue":"5","key":"1706_CR40","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1002\/jps.23065","volume":"101","author":"H Liu","year":"2012","unstructured":"Liu H, Venkatraman SS. Cosolvent Effects on the Drug Release and Depot Swelling in Injectable In situ Depot-Forming Systems. J Pharm Sci. 2012;101(5):1783\u201393. https:\/\/doi.org\/10.1002\/jps.23065.","journal-title":"J Pharm Sci"},{"issue":"1","key":"1706_CR41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1002\/jps.21415","volume":"98","author":"R Astaneh","year":"2009","unstructured":"Astaneh R, Erfan M, Moghimi H, Mobedi H. Changes in morphology of in situ forming PLGA implant prepared by different polymer molecular weight and its effect on release behavior. J Pharm Sci. 2009;98(1):135\u201345. https:\/\/doi.org\/10.1002\/jps.21415.","journal-title":"J Pharm Sci"},{"issue":"3","key":"1706_CR42","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.jconrel.2010.08.020","volume":"147","author":"RB Patel","year":"2010","unstructured":"Patel RB, Solorio L, Wu H, Krupka T, Exner AA. Effect of injection site on in situ implant formation and drug release in vivo. J Control Release. 2010;147(3):350\u20138. https:\/\/doi.org\/10.1016\/j.jconrel.2010.08.020.","journal-title":"J Control Release"},{"issue":"1","key":"1706_CR43","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0142-9612(97)00226-3","volume":"20","author":"S Li","year":"1999","unstructured":"Li S, McCarthy S. Further investigations on the hydrolytic degradation of poly (d,l-lactide). Biomaterials. 1999;20(1):35\u201344. https:\/\/doi.org\/10.1016\/S0142-9612(97)00226-3.","journal-title":"Biomaterials"},{"issue":"2","key":"1706_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/0168-3659(94)90263-1","volume":"30","author":"TG Park","year":"1994","unstructured":"Park TG. Degradation of poly(d,l-lactic acid) microspheres: effect of molecular weight. J Control Release. 1994;30(2):161\u201373. https:\/\/doi.org\/10.1016\/0168-3659(94)90263-1.","journal-title":"J Control Release"},{"issue":"1\u20132","key":"1706_CR45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ijpharm.2011.05.049","volume":"415","author":"S Fredenberg","year":"2011","unstructured":"Fredenberg S, Wahlgren M, Reslow M, Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems\u2014A review. Int J Pharm. 2011;415(1\u20132):34\u201352. https:\/\/doi.org\/10.1016\/j.ijpharm.2011.05.049.","journal-title":"Int J Pharm"},{"issue":"1","key":"1706_CR46","doi-asserted-by":"publisher","first-page":"146","DOI":"10.3109\/03639045.2012.660952","volume":"39","author":"JA Camargo","year":"2013","unstructured":"Camargo JA, Sapin A, Nouvel C, et al. Injectable PLA-based in situ forming implants for controlled release of Ivermectin a BCS Class II drug: solvent selection based on physico-chemical characterization. Drug Dev Ind Pharm. 2013;39(1):146\u201355. https:\/\/doi.org\/10.3109\/03639045.2012.660952.","journal-title":"Drug Dev Ind Pharm"},{"key":"1706_CR47","doi-asserted-by":"publisher","first-page":"123170","DOI":"10.1016\/j.ijpharm.2023.123170","volume":"642","author":"X Wang","year":"2023","unstructured":"Wang X, Bao Q, Wang R, et al. In vivo characterization of Perseris and compositionally equivalent formulations. Int J Pharm. 2023;642:123170. https:\/\/doi.org\/10.1016\/j.ijpharm.2023.123170.","journal-title":"Int J Pharm"},{"issue":"12","key":"1706_CR48","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1002\/jps.24673","volume":"104","author":"L Solorio","year":"2015","unstructured":"Solorio L, Exner AA. Effect of the Subcutaneous Environment on Phase-Sensitive In Situ-Forming Implant Drug Release, Degradation, and Microstructure. J Pharm Sci. 2015;104(12):4322\u20138. https:\/\/doi.org\/10.1002\/jps.24673.","journal-title":"J Pharm Sci"},{"key":"1706_CR49","unstructured":"Coreg CR (Carvedilol phosphate) extended-release capsules: Prescribing information. 2006. Accessed August 6, 2024. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2006\/022012s000_PRNTLBL.pdf"}],"container-title":["Drug Delivery and Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01706-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13346-024-01706-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13346-024-01706-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T06:17:43Z","timestamp":1743833863000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13346-024-01706-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,23]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["1706"],"URL":"https:\/\/doi.org\/10.1007\/s13346-024-01706-7","relation":{},"ISSN":["2190-393X","2190-3948"],"issn-type":[{"value":"2190-393X","type":"print"},{"value":"2190-3948","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,23]]},"assertion":[{"value":"28 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was reviewed and approved by the Institutional Review Board (IRB) committee at the University of Jordan (Number: 20234009), and the study was conducted in accordance with the ethical guidelines imposed by the Nanotechnology Center (formerly the Animal House Unit) and Hamdi Mango Center for Scientific Research at the University of Jordan.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for participation"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}